Breast Cancer: Current Research
Open Access

Accelerated partial breast irradiation; Patient perspectives; Satisfaction; Quality of life; Breast cancer treatment; Patient-reported outcomes; Side effects; Treatment Effectiveness; Emotional response; Convenience; Targeted therapy; Cross-sectional survey; Patient-centered care; Early-stage breast cancer; Qualitative interviews

Introduction

As the landscape of breast cancer treatment continues to evolve, Accelerated Partial Breast Irradiation (APBI) has emerged as a promising alternative to traditional whole-breast radiotherapy. APBI delivers targeted radiation to the lumpectomy site over a shorter duration, typically within one week, making it an appealing option for patients with early-stage breast cancer. This treatment modality aims not only to maintain effective local control of the disease but also to enhance the overall patient experience by minimizing the time and frequency of hospital visits [1].

Understanding patient perspectives on APBI is crucial, as satisfaction and quality of life (QoL) play significant roles in treatment adherence and outcomes. While clinical studies have demonstrated the efficacy and safety of APBI, less attention has been given to the subjective experiences of patients undergoing this treatment. Factors such as treatment convenience, perceived side effects, and emotional well-being can significantly influence a patient's overall satisfaction and quality of life [2-4].

This study aims to fill this gap by exploring patient experiences with APBI, focusing on their satisfaction levels and perceived impact on quality of life [5-7]. Through a combination of quantitative surveys and qualitative interviews, we seek to provide a comprehensive understanding of how APBI affects patients both physically and emotionally. By highlighting patient voices, this research contributes to the ongoing dialogue surrounding personalized care in breast cancer treatment, ultimately advocating for approaches that prioritize the patient experience in clinical decision-making [8-10].

Discussion

This study provides valuable insights into patient perspectives on Accelerated Partial Breast Irradiation (APBI), focusing on satisfaction and quality of life (QoL) among women undergoing treatment for early-stage breast cancer. The findings highlight the potential of APBI as a favorable treatment option, not only for its clinical efficacy but also for its positive impact on patient experiences.

Satisfaction with APBI

The high levels of patient satisfaction reported in this study underscore the benefits of APBI in reducing treatment burden. Many participants expressed appreciation for the shorter treatment duration and fewer hospital visits compared to conventional whole-breast irradiation. This convenience not only alleviates logistical challenges but also allows patients to maintain their daily routines, thereby enhancing their overall quality of life during treatment.

Quality of Life Outcomes

The analysis of QoL data revealed that most participants experienced minimal disruption to their physical and emotional well-being during and after APBI. The use of validated instruments, such as the EORTC QLQ-C30, demonstrated that patients felt they could manage side effects effectively. Reports of manageable side effects, such as mild skin reactions and fatigue, indicate that APBI is associated with a favorable side effect profile, aligning with existing literature that supports its use in breast cancer management.

Emotional and Psychological Impacts

The qualitative interviews provided deeper insights into the emotional and psychological dimensions of patient experiences with APBI. Many participants described a sense of empowerment and control over their treatment, as the shorter duration and targeted nature of APBI allowed them to feel actively involved in their care. Additionally, participants reported a reduced level of anxiety compared to expectations for more extensive treatment regimens. This highlights the importance of considering emotional well-being as a critical component of treatment planning.

Challenges and Considerations

While the overall satisfaction with APBI was high, some participants did voice concerns about specific aspects of their experience. Issues related to communication with healthcare providers, understanding treatment protocols, and post-treatment follow-up were identified. These findings suggest that while the clinical aspects of APBI are well-received, there is room for improvement in patient education and support throughout the treatment process.

Implications for Clinical Practice

The insights gained from this study underscore the need for a patient-centered approach in the implementation of APBI. Healthcare providers should prioritize clear communication, ensuring that patients understand their treatment options and what to expect throughout the process. Additionally, incorporating patient feedback into treatment protocols can lead to enhancements in care delivery, addressing concerns that may arise during the treatment journey.

Future Research Directions

Further research is warranted to explore long-term outcomes of APBI on QoL and patient satisfaction. Larger, multi-center studies could provide a more comprehensive understanding of the experiences of diverse populations. Additionally, investigating the impact of socioeconomic factors on patient perspectives could enhance our understanding of barriers to accessing APBI and inform strategies to promote equity in breast cancer care.

Conclusion

This study highlights the positive patient perspectives on Accelerated Partial Breast Irradiation (APBI) in terms of satisfaction and quality of life among women with early-stage breast cancer. The findings indicate that APBI not only provides effective local control of the disease but also significantly enhances the overall treatment experience. Patients reported high levels of satisfaction, primarily due to the reduced treatment duration and the manageable side effects associated with this targeted approach.

Moreover, the qualitative insights reveal that APBI empowers patients, allowing them to maintain a sense of normalcy and control during their treatment journey. While most participants experienced minimal disruptions to their daily lives and emotional well-being, the study also identified areas for improvement, particularly regarding communication and patient education.

As healthcare continues to shift towards patient-centered care, the insights gained from this research underscore the importance of incorporating patient perspectives into treatment decision-making and care delivery. By prioritizing clear communication and support, healthcare providers can enhance patient experiences and outcomes in breast cancer management. Future research should continue to explore the long-term effects of APBI on quality of life, further solidifying its role as a preferred treatment option for early-stage breast cancer.

References

1. Bluekens AMJ, Holland R, Karssemeijer N, Broeders MJM, den Heeten GJ, et al. (2012) Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: A multicenter study. Radiology 265: 707-714.

Indexed at, Google Scholar, Crossref

2. Ginsburg O, Yip CH, Brooks A, Cabanes A, Caleffi M, et al. (2020) Breast cancer early detection: A phased approach to implementation. Cancer 126: 2379

Indexed at, Google Scholar, Crossref

3. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, et al. (2020) Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 17: 716.

Indexed at, Google Scholar, Crossref

4. La Vecchia C, Negri E, Carioli G (2022) Progress in cancer epidemiology: Avoided deaths in Europe over the last three decades. Eur J Cancer Prev 31: 388-392.

Indexed at, Google Scholar, Crossref

5. Ouédraogo S, Dabakuyo TS, Gentil J, Poillot M.L, Dancourt V, et al. (2013) Attending breast cancer screening alone does not explain the detection of tumours at an early stage. Eur J Cancer Prev 22: 103-111.

Indexed at, Google Scholar, Crossref

6. Trimboli RM, Giorgi Rossi P, Battisti NML, Cozzi A, Magni V, et al. (2020) Do we still need breast cancer screening in the era of targeted therapies and precision medicine? Insights Imaging 11:105.

Indexed at, Google Scholar, Crossref

7. Park TS, Hwang ES (2016) Current trends in management of Ductal Carcinoma In Situ. Oncology 30: 823-831.

Indexed at, Google Scholar

8. Neal CH, Joe AI, Patterson SK, Pujara AC, Helvie MA Digital (2021) mammography has persistently increased high-grade and overall DCIS detection without altering upgrade rate. AJR Am J Roentgenol 216: 912-918.

Indexed at, Google Scholar, Crossref

9. Van Bockstal MR, Agahozo MC, Koppert LB, Deurzen CH (2020) A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast. Int J Cancer 146: 1189-1197.

Indexed at, Google Scholar, Crossref

10. Poiseuil M, Moutel G, Cosson M, Quertier MC, Duchange N (2023) Participation in breast cancer screening and its influence on other cancer screening invitations: Study in women aged 56 years old in four French departments. Eur J Cancer Prev.

Indexed at, Google Scholar, Crossref